tiprankstipranks
Trending News
More News >
Naya Biosciences, Inc. (NAYA)
NASDAQ:NAYA
US Market

NAYA Biosciences (NAYA) Stock Statistics & Valuation Metrics

Compare
155 Followers

Total Valuation

NAYA Biosciences has a market cap or net worth of $2.03M. The enterprise value is ―.
Market Cap$2.03M
Enterprise Value

Share Statistics

NAYA Biosciences has 1,066,065 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,066,065
Owned by Insiders
Owned by Institutions<0.01%

Financial Efficiency

NAYA Biosciences’s return on equity (ROE) is -9.00 and return on invested capital (ROIC) is -55.69%.
Return on Equity (ROE)-9.00
Return on Assets (ROA)-0.43
Return on Invested Capital (ROIC)-55.69%
Return on Capital Employed (ROCE)-0.64
Revenue Per Employee100.69K
Profits Per Employee-267.82K
Employee Count30
Asset Turnover0.16
Inventory Turnover7.31

Valuation Ratios

The current PE Ratio of NAYA Biosciences is -5.99. NAYA Biosciences’s PEG ratio is -0.09.
PE Ratio-5.99
PS Ratio0.00
PB Ratio-333.33
Price to Fair Value53.88
Price to FCF-0.41
Price to Operating Cash Flow-2.53
PEG Ratio-0.09

Income Statement

In the last 12 months, NAYA Biosciences had revenue of 3.02M and earned -8.03M in profits. Earnings per share was -5.13.
Revenue3.02M
Gross Profit1.09M
Operating Income-6.77M
Pretax Income-8.01M
Net Income-8.03M
EBITDA-6.88M
Earnings Per Share (EPS)-5.13

Cash Flow

In the last 12 months, operating cash flow was -3.07M and capital expenditures -179.83K, giving a free cash flow of -3.25M billion.
Operating Cash Flow-3.07M
Free Cash Flow-3.25M
Free Cash Flow per Share-3.05

Dividends & Yields

NAYA Biosciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.07
52-Week Price Change-82.91%
50-Day Moving Average2.32
200-Day Moving Average7.14
Relative Strength Index (RSI)47.88
Average Volume (3m)4.39M

Important Dates

NAYA Biosciences upcoming earnings date is May 19, 2025, TBA Not Confirmed.
Last Earnings DateApr 30, 2025
Next Earnings DateMay 19, 2025
Ex-Dividend Date

Financial Position

NAYA Biosciences as a current ratio of 0.16, with Debt / Equity ratio of -22882.39%
Current Ratio0.16
Quick Ratio0.12
Debt to Market Cap0.06
Net Debt to EBITDA-0.88
Interest Coverage Ratio-7.31

Taxes

In the past 12 months, NAYA Biosciences has paid 27.79K in taxes.
Income Tax27.79K
Effective Tax Rate>-0.01

Enterprise Valuation

NAYA Biosciences EV to EBITDA ratio is -7.87, with an EV/FCF ratio of -10.42.
EV to Sales17.94
EV to EBITDA-7.87
EV to Free Cash Flow-10.42
EV to Operating Cash Flow-11.39

Balance Sheet

NAYA Biosciences has $471.59K in cash and marketable securities with $5.34M in debt, giving a net cash position of $4.86M billion.
Cash & Marketable Securities$471.59K
Total Debt$5.34M
Net Cash$4.86M
Net Cash Per Share$4.56
Tangible Book Value Per Share-$2.90

Margins

Gross margin is 42.40%, with operating margin of -224.04%, and net profit margin of -266.00%.
Gross Margin42.40%
Operating Margin-224.04%
Pretax Margin-265.08%
Net Profit Margin-266.00%
EBITDA Margin-227.77%
EBIT Margin-234.42%

Analyst Forecast

The average price target for NAYA Biosciences is $2.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$2.00
Price Target Upside5.26% Upside
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast390.03%
EPS Growth Forecast84.00%

Scores

Smart ScoreN/A
AI Score39
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis